CN1144477A - 低粘度的眼药组合物 - Google Patents
低粘度的眼药组合物 Download PDFInfo
- Publication number
- CN1144477A CN1144477A CN95192185A CN95192185A CN1144477A CN 1144477 A CN1144477 A CN 1144477A CN 95192185 A CN95192185 A CN 95192185A CN 95192185 A CN95192185 A CN 95192185A CN 1144477 A CN1144477 A CN 1144477A
- Authority
- CN
- China
- Prior art keywords
- amount
- compositions
- agent
- viscosity
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Abstract
Description
Claims (12)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9401108-7 | 1994-03-31 | ||
SE9401108A SE9401108D0 (sv) | 1994-03-31 | 1994-03-31 | Ophthalmic composition I |
SE94011087 | 1994-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1144477A true CN1144477A (zh) | 1997-03-05 |
CN1112918C CN1112918C (zh) | 2003-07-02 |
Family
ID=20393511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95192185A Expired - Fee Related CN1112918C (zh) | 1994-03-31 | 1995-03-29 | 低粘度的眼药组合物 |
Country Status (27)
Country | Link |
---|---|
US (1) | US5710182A (zh) |
EP (1) | EP0752847B1 (zh) |
JP (1) | JPH10503470A (zh) |
KR (1) | KR100365914B1 (zh) |
CN (1) | CN1112918C (zh) |
AT (1) | ATE202921T1 (zh) |
AU (1) | AU694497B2 (zh) |
BG (1) | BG63145B1 (zh) |
BR (1) | BR9507438A (zh) |
CA (1) | CA2186734A1 (zh) |
CZ (1) | CZ290987B6 (zh) |
DE (2) | DE752847T1 (zh) |
DK (1) | DK0752847T3 (zh) |
EE (1) | EE03661B1 (zh) |
ES (1) | ES2161874T3 (zh) |
GR (1) | GR3036763T3 (zh) |
HK (1) | HK1013953A1 (zh) |
HU (1) | HU223071B1 (zh) |
MX (1) | MX9603918A (zh) |
NO (1) | NO314434B1 (zh) |
PL (1) | PL179433B1 (zh) |
PT (1) | PT752847E (zh) |
RO (1) | RO115409B1 (zh) |
RU (1) | RU2139016C1 (zh) |
SE (1) | SE9401108D0 (zh) |
SK (1) | SK280492B6 (zh) |
WO (1) | WO1995026711A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110621298A (zh) * | 2017-05-11 | 2019-12-27 | 内瓦卡有限公司 | 阿托品药物组合物 |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9718568D0 (en) | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
WO2000064528A1 (en) | 1999-04-28 | 2000-11-02 | Situs Corporation | Drug delivery system |
US6852688B2 (en) | 2000-03-10 | 2005-02-08 | University Of Florida | Compositions for treating diabetic retinopathy and methods of using same |
EP1484054B1 (en) * | 2002-02-22 | 2012-08-29 | Santen Pharmaceutical Co., Ltd. | Drug delivery system for the subconjunctival administration of fine grains |
BR0307893A (pt) * | 2002-02-22 | 2004-12-07 | Pharmacia Corp | Formulação oftálmica com sistema de goma |
JP2004196787A (ja) * | 2002-12-04 | 2004-07-15 | Santen Pharmaceut Co Ltd | 結膜下デポによるドラッグデリバリーシステム |
AU2003289127A1 (en) * | 2002-12-04 | 2004-06-23 | Santen Pharmaceutical Co., Ltd. | Drug delivery system using subconjunctival depot |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
CA2839849C (en) * | 2003-06-13 | 2017-03-07 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
EP1666025A4 (en) * | 2003-08-20 | 2011-08-31 | Santen Pharmaceutical Co Ltd | DRUG DELIVERY SYSTEM FOR THE SUBTENOIN DELIVERY OF FINE GRAINS |
TWI367098B (en) * | 2004-12-23 | 2012-07-01 | Kowa Co | Treating agent for glaucoma |
US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
DE102005035986B4 (de) * | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat |
EP2334686B1 (en) | 2008-08-28 | 2019-02-27 | President and Fellows of Harvard College | Cortistatin analogues and syntheses therof |
EP2383286A1 (en) | 2010-04-30 | 2011-11-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for treatment of retinal degenerative diseases |
TW201309343A (zh) * | 2011-02-10 | 2013-03-01 | 參天製藥股份有限公司 | 經改善親水性藥物之藥物移行性之水性組成物 |
US20150038557A1 (en) | 2012-02-24 | 2015-02-05 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for treatment of retinal degenerative diseases |
WO2015100420A1 (en) | 2013-12-24 | 2015-07-02 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
EP3340982B1 (en) | 2015-08-26 | 2021-12-15 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
CA3014774A1 (en) | 2016-02-17 | 2017-08-24 | Children's Medical Center Corporation | Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders |
CA3029262A1 (en) | 2016-06-27 | 2018-01-04 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
WO2018033854A1 (en) * | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
US9867810B1 (en) | 2016-08-19 | 2018-01-16 | Orasis Pharmaceuticals Ltd. | Ophthalmic pharmaceutical compositions and uses relating thereto |
EP3773576A4 (en) | 2018-03-26 | 2021-12-29 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
EP3841086A4 (en) | 2018-08-20 | 2022-07-27 | Achillion Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D |
CN113365617A (zh) | 2018-10-16 | 2021-09-07 | 乔治亚州立大学研究基金会股份有限公司 | 用于医学疾病治疗的一氧化碳前药 |
CA3205883A1 (en) * | 2021-02-04 | 2022-08-11 | Gregory I. Ostrow | Ophthalmic compositions for presbyopia |
EP4088713A1 (en) | 2021-05-10 | 2022-11-16 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic pharmaceutical composition comprising atropine |
EP4088714A1 (en) | 2021-05-10 | 2022-11-16 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic pharmaceutical composition comprising atropine |
CN113786380A (zh) * | 2021-09-18 | 2021-12-14 | 华北制药股份有限公司 | 一种硝酸毛果芸香碱眼用凝胶及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6056684B2 (ja) * | 1977-11-07 | 1985-12-11 | 東興薬品工業株式会社 | 点眼剤 |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
FR2678832B1 (fr) * | 1991-07-10 | 1995-03-17 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. |
-
1994
- 1994-03-31 SE SE9401108A patent/SE9401108D0/xx unknown
-
1995
- 1995-03-29 EE EE9600120A patent/EE03661B1/xx unknown
- 1995-03-29 AT AT95914362T patent/ATE202921T1/de active
- 1995-03-29 HU HU9602691A patent/HU223071B1/hu active IP Right Grant
- 1995-03-29 BR BR9507438A patent/BR9507438A/pt not_active IP Right Cessation
- 1995-03-29 DE DE0752847T patent/DE752847T1/de active Pending
- 1995-03-29 CA CA002186734A patent/CA2186734A1/en not_active Abandoned
- 1995-03-29 CN CN95192185A patent/CN1112918C/zh not_active Expired - Fee Related
- 1995-03-29 RO RO96-01877A patent/RO115409B1/ro unknown
- 1995-03-29 PT PT95914362T patent/PT752847E/pt unknown
- 1995-03-29 KR KR1019960705391A patent/KR100365914B1/ko not_active IP Right Cessation
- 1995-03-29 DE DE69521686T patent/DE69521686T2/de not_active Expired - Lifetime
- 1995-03-29 WO PCT/FI1995/000166 patent/WO1995026711A1/en active IP Right Grant
- 1995-03-29 JP JP7525423A patent/JPH10503470A/ja not_active Ceased
- 1995-03-29 RU RU96119953A patent/RU2139016C1/ru active
- 1995-03-29 US US08/535,037 patent/US5710182A/en not_active Expired - Lifetime
- 1995-03-29 AU AU21389/95A patent/AU694497B2/en not_active Ceased
- 1995-03-29 SK SK1239-96A patent/SK280492B6/sk not_active IP Right Cessation
- 1995-03-29 PL PL95316584A patent/PL179433B1/pl unknown
- 1995-03-29 CZ CZ19962865A patent/CZ290987B6/cs not_active IP Right Cessation
- 1995-03-29 ES ES95914362T patent/ES2161874T3/es not_active Expired - Lifetime
- 1995-03-29 EP EP95914362A patent/EP0752847B1/en not_active Expired - Lifetime
- 1995-03-29 DK DK95914362T patent/DK0752847T3/da active
- 1995-03-29 MX MX9603918A patent/MX9603918A/es unknown
-
1996
- 1996-09-27 NO NO19964070A patent/NO314434B1/no not_active IP Right Cessation
- 1996-10-16 BG BG100915A patent/BG63145B1/bg unknown
-
1998
- 1998-12-23 HK HK98115146A patent/HK1013953A1/xx not_active IP Right Cessation
-
2001
- 2001-09-28 GR GR20010401621T patent/GR3036763T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110621298A (zh) * | 2017-05-11 | 2019-12-27 | 内瓦卡有限公司 | 阿托品药物组合物 |
CN110621298B (zh) * | 2017-05-11 | 2022-12-20 | 维卢玛有限公司 | 阿托品药物组合物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1112918C (zh) | 低粘度的眼药组合物 | |
CN1114399C (zh) | 含离子敏感的亲水聚合物和无机盐的低粘度的眼药组合物 | |
CN1082371C (zh) | 用于治疗呕吐的nk-1受体拮抗剂和5ht3受体拮抗剂 | |
CN1162148C (zh) | 含有纤维素醚的热凝胶药物转运载体 | |
CN1684689A (zh) | 由Rho激酶抑制剂和前列腺素类物质构成的青光眼治疗剂 | |
CN1311670A (zh) | 胆碱能试剂在治疗老花眼中的应用 | |
CN1711107A (zh) | 由 Rho 激酶抑制剂和β阻断剂构成的青光眼治疗剂 | |
CN1089837A (zh) | 眼用制剂 | |
CN1407903A (zh) | 治疗青光眼用并用剂 | |
CN1270707C (zh) | 滴眼液 | |
CN1348367A (zh) | 含有羟丁宁的透皮吸收制剂 | |
CN1126545C (zh) | 眼科用制剂 | |
CN1137679C (zh) | 水溶性滴眼剂 | |
EP0577913A1 (en) | Pharmaceutical preparation | |
CN1732928A (zh) | 氟康唑眼用制剂及其制备方法 | |
FI117921B (fi) | Alennetun viskositeetin omaava oftalminen koostumus | |
CN1943590A (zh) | 一种治疗干眼症的人工泪液 | |
CN1583744A (zh) | 治疗近视眼的哌仑西平有机酸盐及其滴眼剂 | |
CN1850274A (zh) | 包含有脂溶性化合类药物的纳米复合物滴眼液及其制备方法 | |
CN1579402A (zh) | 一种治疗细菌性结膜炎、角膜炎的药物组合物及其制备方法 | |
CN1481795A (zh) | 一种局部眼用制剂 | |
CN87103415A (zh) | 稳定的、注射用的止吐剂的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Tampere, Finland Applicant after: Santon Co. Address before: Turku, Finland Applicant before: Leiras OY |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: LEIRAS OY TO: THORNTON CO.,LTD. |
|
ASS | Succession or assignment of patent right |
Owner name: THORNTON MEDICINE CO., LTD. Free format text: FORMER OWNER: THORNTON CO.,LTD. Effective date: 20020411 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20020411 Address after: Osaka Prefecture, Japan Applicant after: Sunton Medicine Co., Ltd. Address before: Tampere, Finland Applicant before: Santon Co. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |